000 01220 a2200337 4500
005 20250516063942.0
264 0 _c20120604
008 201206s 0 0 eng d
022 _a1440-1711
024 7 _a10.1038/icb.2011.99
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIyer, Abishek
245 0 0 _aLysine acetylation in obesity, diabetes and metabolic disease.
_h[electronic resource]
260 _bImmunology and cell biology
_cJan 2012
300 _a39-46 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aCardiovascular Diseases
_ximmunology
650 0 4 _aDiabetes Mellitus, Type 2
_ximmunology
650 0 4 _aEnergy Metabolism
_xdrug effects
650 0 4 _aHistone Acetyltransferases
_xmetabolism
650 0 4 _aHistone Deacetylase Inhibitors
_xpharmacology
650 0 4 _aHistone Deacetylases
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLysine
_xmetabolism
650 0 4 _aObesity
_ximmunology
700 1 _aFairlie, David P
700 1 _aBrown, Lindsay
773 0 _tImmunology and cell biology
_gvol. 90
_gno. 1
_gp. 39-46
856 4 0 _uhttps://doi.org/10.1038/icb.2011.99
_zAvailable from publisher's website
999 _c21311769
_d21311769